How Are Peptides Made?

Three routes to the same molecule

Peptide manufacturing is not one process. The sequence, the quantity and the modification load determine which route is used. Chemical synthesis builds the chain from protected amino acids, recombinant expression builds it in a host cell, and hybrid approaches join fragments made by either method.

For custom research supply, solid-phase synthesis dominates because it is fast, flexible and easy to scale from milligrams to grams. For a commodity peptide needed in tonnes, a liquid-phase or recombinant route may win on cost. The decision is economic and technical, not a matter of one method being better.

This article describes the chemistry at a process level. It is technical information for laboratory and manufacturing readers, not guidance for making peptides at home or using them in humans.

Solid-phase peptide synthesis, step by step

In SPPS the chain is assembled while attached to an insoluble resin bead. Because the resin can be filtered and washed, excess reagents are removed without a purification step after each reaction. That single design choice is what made routine peptide synthesis possible.

1. Resin selection: a linker is chosen for the required C-terminal group. Wang and Rink amide linkers give an acid or an amide respectively; the choice affects the final charge and stability.
2. Swelling: the resin is swollen in a solvent such as dimethylformamide so reagents can reach the polymer interior.
3. Deprotection: the Fmoc group on the growing chain is removed with piperidine in DMF, freeing the amino group for the next coupling.
4. Coupling: the next protected amino acid is activated, usually with HBTU, HATU or DIC and an additive, then added to the resin. Coupling is monitored and repeated if incomplete.
5. Capping: unreacted chains are acetylated so they cannot grow after a missed coupling, which simplifies purification.
6. Cleavage: a mixture such as trifluoroacetic acid with water and scavengers releases the peptide and removes side-chain protecting groups in one step.
7. Precipitation: the cleaved peptide is precipitated in cold ether, centrifuged and dried before purification.

Each cycle adds one residue. A 30-mer therefore needs about 30 deprotections and 30 couplings, and the cumulative yield of that sequence of steps is what determines how much crude peptide reaches purification.

Liquid-phase synthesis and when it is the better choice

Liquid-phase peptide synthesis runs the same chemistry in solution, with purification after each step by crystallization or extraction. It is slower and less flexible than SPPS, but it avoids the cost of resin and the large solvent volumes needed to wash a solid support.

Liquid-phase methods are attractive for short peptides produced in large quantities, especially where a crystalline intermediate can be isolated at high purity. They are also used for fragments that will later be joined by ligation, where a highly purified building block is worth the extra effort.

In practice, most custom suppliers use SPPS for the bulk of a sequence and liquid-phase chemistry for specific steps, such as the final acylation, lipidation or conjugation that would be awkward on resin.

Recombinant and enzymatic production routes

Recombinant production expresses the peptide as part of a larger protein in bacteria, yeast or mammalian cells, then releases it by cleavage and purifies it by chromatography. It is the standard route for insulin and other large peptide hormones, and it becomes economical when the required quantity is high and the sequence is unmodified.

The trade-off is control. Expression cannot easily incorporate D-amino acids, non-natural residues or site-specific labels, and it adds concerns about host cell proteins, endotoxin and post-translational heterogeneity. Those attributes have to be tested and documented.

Enzymatic ligation sits in between. Enzymes such as sortase or subtiligase join two peptides under mild aqueous conditions, which allows fragments from different routes to be combined. Native chemical ligation achieves something similar chemically, through a thioester and an N-terminal cysteine, and is the standard approach for very long synthetic targets.

Comparing the manufacturing routes

Most custom orders sit in the first row. When a sequence is long or heavily modified, the quote should state which route is planned, because that choice drives both price and timeline.

Cleavage, purification and lyophilization

Crude peptide after cleavage is a mixture: the target, deletion sequences, oxidized products, residual protecting group adducts and salts. Reverse-phase HPLC separates them on a C18 or C8 column with a water and acetonitrile gradient, and fractions are checked by analytical HPLC and mass spectrometry before pooling.

Pooled fractions are concentrated and lyophilized. The freeze-drying cycle matters: a peptide with a high salt content can collapse into a glassy cake that is hard to dissolve, and a hydrophobic sequence can aggregate during drying. Formulation with a counter-ion such as acetate or trifluoroacetate is chosen to match the intended use.

MOL Changes reports purity by HPLC up to 98%+ depending on sequence, with each batch accompanied by a chromatogram, a mass spectrum and a certificate of analysis. The purity testing guide explains how the number is derived, and storage guidance covers what to do with the powder after delivery.

What drives lead time and cost

Sequence length is the first driver. Every residue adds two reactions and a set of washes, and difficult couplings lower the yield of everything that follows. Hydrophobic stretches and beta-sheet motifs cause on-resin aggregation, which slows coupling and increases deletion products.

Cysteine content adds a separate problem. Multiple cysteines require selective protection and controlled oxidation to form the correct disulfide pattern, and the folding step can fail in ways that are hard to predict. Unusual modifications, non-natural residues and labels each add a step and a validation point.

Purity target and quantity complete the picture. Moving from 90 to 95 percent purity can double the chromatography burden, and scaling from 10 mg to 100 g changes equipment, solvent handling and quality documentation. Standard sequences at MOL Changes typically run two to four weeks; complex projects are quoted with a schedule after sequence review. Request a quote with your sequence and target quantity to get a specific timeline.